ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 872,48
-0,32%
Dow Jones
44 713,52
-0,31%
DAX
21 637,53
0,93%
Brent Oil
75,815
-1,04%
Bitcoin
103 920,52
2,54%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Recursion Pharmaceuticals Inc (RXRX) Cours

Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals Inc (RXRX)

NASDAQ
7,1571
-0,2729
( -3,67% )
Mis à jour : 21:53:15
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
7,1571
Prix Achat
7,15
Prix Vente
7,16
Volume échangé
11 815 984
6,945 Fourchette du Jour 7,75
5,61 Plage de 52 semaines 15,74
Cap du marché
2,052B
Clôture Veille
7,43
Ouverture
7,42
Dernière Transaction
1
@
7.1794
Dernière heure de transaction
21:53:15
Volume financier
US$ 86 135 404
VWAP
7,2897
Volume moyen (3 m)
14 630 182
Actions en circulation
286 640 833
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-6,25
Bénéfice par action (BPA)
-1,14
Chiffre d'affairess
44,58M
Bénéfice net
-328,07M

À propos de Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery... Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.recursion.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Recursion Pharmaceuticals Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker RXRX. Le dernier cours de clôture d'Recursion Pharmaceuticals était de US$7,43. Au cours de la dernière année, les actions de Recursion Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 5,61 à US$ 15,74.

Recursion Pharmaceuticals compte actuellement 286 640 833 actions en circulation. La capitalisation boursière d'Recursion Pharmaceuticals est de US$2,13 milliard. Recursion Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -6.25.

Flux d'options Recursion Pharmaceuticals (RXRX)

Voir le flux d'options complet

Flux global

Haussier

Prime nette

14k

Calls / Puts

200,00%

Ach. / Vent.

200,00%

OTM / ITM

200,00%

Sweeps Ratio

0,00%

RXRX Dernières nouvelles

Plus de nouvelles

Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028

Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028 PR Newswire VANCOUVER, BC, Jan. 17, 2025 USA News Group News Commentary  Issued on behalf of Avant Technologies...

17 Janvier 2025
PR Newswire (US)

Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028

Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028 PR Newswire VANCOUVER, BC, Jan. 17, 2025 USA News Group News Commentary  Issued on behalf of Avant Technologies...

17 Janvier 2025
PR Newswire (US)

Form 144 - Report of proposed sale of securities

17 Janvier 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

15 Janvier 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

14 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

13 Janvier 2025
Edgar (US Regulatory)

Form 8-K - Current report

13 Janvier 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

10 Janvier 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

08 Janvier 2025
Edgar (US Regulatory)

Recursion Announces Two Key Investigational Oncology Drugs Advancing to Clinical Trials, Targeting High Unmet Needs in Hematologic Malignancies, Small-Cell Lung Cancer, & More

REC-3565 is a potential best-in-class MALT1 inhibitor for multiple hematology indications, designed to reduce the risk of hyperbilirubinemia, a common side effect of other MALT1 inhibitors...

07 Janvier 2025
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.0129-0.1799163179927.178.2456.72227904547.33185105CS
40.26713.876632801166.898.666.2166390787.15577343CS
120.20712.979856115116.959.555.61146301827.02743958CS
26-1.2029-14.38875598098.369.555.6189979566.93509755CS
52-2.6429-26.96836734699.815.745.6174426198.11777876CS
156-3.6229-33.60760667910.7816.7454.5441682998.67692218CS
260-22.8429-76.1433042.814.5434783069.38189914CS

RXRX - Frequently Asked Questions (FAQ)

What is the current Recursion Pharmaceuticals share price?
The current share price of Recursion Pharmaceuticals is US$ 7,1571
How many Recursion Pharmaceuticals shares are in issue?
Recursion Pharmaceuticals has 286 640 833 shares in issue
What is the market cap of Recursion Pharmaceuticals?
The market capitalisation of Recursion Pharmaceuticals is USD 2,13B
What is the 1 year trading range for Recursion Pharmaceuticals share price?
Recursion Pharmaceuticals has traded in the range of US$ 5,61 to US$ 15,74 during the past year
What is the PE ratio of Recursion Pharmaceuticals?
The price to earnings ratio of Recursion Pharmaceuticals is -6,25
What is the cash to sales ratio of Recursion Pharmaceuticals?
The cash to sales ratio of Recursion Pharmaceuticals is 45,98
What is the reporting currency for Recursion Pharmaceuticals?
Recursion Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Recursion Pharmaceuticals?
The latest annual turnover of Recursion Pharmaceuticals is USD 44,58M
What is the latest annual profit for Recursion Pharmaceuticals?
The latest annual profit of Recursion Pharmaceuticals is USD -328,07M
What is the registered address of Recursion Pharmaceuticals?
The registered address for Recursion Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Recursion Pharmaceuticals website address?
The website address for Recursion Pharmaceuticals is www.recursion.com
Which industry sector does Recursion Pharmaceuticals operate in?
Recursion Pharmaceuticals operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AALAmerican Airlines Group Inc
US$ 0,00
(0,00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0,00
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 0,00
(0,00%)
0
AADIAadi Bioscience Inc
US$ 0,00
(0,00%)
0
AACGATA Creativity Global
US$ 0,00
(0,00%)
0
AALAmerican Airlines Group Inc
US$ 0,00
(0,00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0,00
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 0,00
(0,00%)
0
AADIAadi Bioscience Inc
US$ 0,00
(0,00%)
0
AACGATA Creativity Global
US$ 0,00
(0,00%)
0
AALAmerican Airlines Group Inc
US$ 0,00
(0,00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0,00
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 0,00
(0,00%)
0
AADIAadi Bioscience Inc
US$ 0,00
(0,00%)
0
AACGATA Creativity Global
US$ 0,00
(0,00%)
0

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
RXRX
Recursion Pharmaceuticals
NASDAQI
CRSPUTT
CRSP US Utilities Total ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces